Steve Popper: Knicks better equipped to handle OG Anunoby's absence if he misses extended time

OG Anunoby is listed as questionable for Game 3 after exiting Game 2 with a right hamstring issue, while Josh Hart is also questionable and Mitchell Robinson is probable to return. The Knicks were 8-7 without Anunoby this season, suggesting some resilience thanks to added depth from Karl-Anthony Towns and Mikal Bridges, though losing Anunoby would still reduce size and versatility. Joel Embiid is also questionable for Philadelphia, keeping the series status fluid but with limited broader market relevance.

Analysis

This is less about one player’s availability than about whether the market is underestimating playoff injury asymmetry: a short hamstring absence matters most when it hits a team’s weakest replaceable skill, and Anunoby’s value sits in the exact overlap of size, switching, and low-usage offense. The Knicks are no longer a one-creator roster, so a brief gap should compress their title probability only modestly, but it does raise the volatility of individual game outcomes because their margin for error on the wing narrows sharply.

The second-order effect is on substitution economics. If they pivot to smaller, more shooting-heavy lineups, they may preserve spacing but lose the defensive elasticity that lets them survive opponent runs; if they choose size replacements, they risk depressing half-court efficiency. That tradeoff is most dangerous on the road over a 2-3 game horizon, where whistle variance and role-player shooting typically swing series pricing faster than star availability news.

The bigger market misread is likely in the opponent leg, not the Knicks leg: any credible expectation that Philadelphia gets Embiid back meaningfully increases the chance of a short series extension and makes the next 48 hours a classic overreaction window. But if Anunoby is out and Embiid returns, the series becomes a possession-by-possession coin flip rather than a clean Knicks advantage, which should flatten enthusiasm around New York while lifting live-game volatility.

Over a multi-month horizon, this is not a franchise-level blow unless the hamstring aggravates, because the Knicks’ roster construction is now robust enough to absorb one wing absence better than in prior seasons. The tail risk is a recurrence that changes not just this series but the health discount embedded in next season’s expectations for an aging, high-minutes core. That creates a clean distinction between a one-game trade and a series-long risk premium.

Key Decisions for Investors

• Avoid chasing Knicks upside outright into Game 3; if trading the series, prefer buying volatility via live-betting or correlated event exposure rather than a straight directional Knicks position, because the injury-news premium is likely already embedded.
• If Anunoby is ruled out and Embiid is cleared, look for a short-term fade of Knicks series pricing or a hedge via opponent game spreads for the next 1-2 games; the best risk/reward is on market overreaction to a single availability update.
• Use a two-leg catalyst trade: long playoff volatility, short complacency — express through in-game betting markets or derivative-style exposures only after official injury reports, since the gap between questionable and active should create a fast repricing window.
• If the hamstring absence extends beyond one game, treat it as a series-duration downgrade rather than a panic event: reduce any Knicks long exposure by 25-50% rather than flipping outright, because roster depth lowers but does not eliminate the probability of winning at least one road game.
• Contrarian angle: if the market sells Knicks too hard on the injury, consider re-entering after a loss with better price, since the team’s structural advantage versus Philadelphia is still driven by Brunson/Towns creation and the injury mostly trims margin, not baseline win probability.